Ingredient Identity rebrands to honor founder, highlight expansion plans

By Hank Schultz contact

- Last updated on GMT

Ingredient Identity/REJIMUS photo
Ingredient Identity/REJIMUS photo
A rebrand of consulting firm Ingredient Identity reflects the company’s expansion ambitions as well as honoring its founder.

The new name—REJIMUS—builds on the concept of the word ‘regimented’ and is pronounced similarly. And it contains within it the first name of the company’s founder and COO Jim Lassiter, who has more than 30 years experience in the natural products industry, having started the firm in 2011 after previous stints at such prominent industry names as Nutrilite, Robinson Pharma and ChromaDex.

New name looks forward as well as back

“The name REJIMUS represents a new stage of growth and expansion beyond a boutique regulatory consultancy, into a true regulatory solution provider and strategic partner for our clients no matter their size,”​ said Brandon Griffin, CEO of REJIMUS. 

“The new name builds on a number of things,” ​Griffin told NutraIngredients-USA. “Simplicity was one of the things we were going for, like any brand.  But also regimented—speaking to a discipline.  And we wanted to honor the legacy of our founder, and having “Jim” in the name was a clever way to do that.”

Expansion plans

Griffin said the rebrand will be part of an ambitious expansion plan for the company for 2019 that will include the following:

  • Cost-effective and personalized GMP Training and other specialty regulatory/labeling workshops at the corporate headquarters in Santa Ana, CA
  • Business auditing and regulatory operational optimization with quarterly and annual performance monitoring to achieve key performance indicators and/or budgeting requirements
  • Online Label Claims Library that is ingredient/source driven to facilitate a robust practice of compliant marketing efforts out of the gate and drive formulation efforts
  • Partnering with clinical research partners to support protocol refinement, claims substantiation and/or claims development efforts for marketing and other regulatory submission purposes
  • Substantial increased capacity for Finished Product Label/Packaging Reviews and Claims Substantiation Dossiers
  • Dedicated department staff specialized in GRAS and NDI Notification projects
  • The launch of an independent and dedicated Project Management department and team to ensure timely management of complex projects or high-volume work requests
  • Custom Compliant Label Design services to ensure proper format setup and editing, based on desired packaging configuration/sizing.

Griffin said the expansion plans will help the company better execute on existing competencies.

“We can coordinate with a company’s product development folks,”​ he said. “With our expanded claims libraries, we can make sure that claims don’t have to get thrown our or altered along the way. We can make sure that from the beginning in a formulation, adequate ingredient amounts are included to support claims.”

Contract research consulting

Griffin said the rebranded company is also planning to help clients better support their product development efforts via more efficient clinical study design. He said the one size fits all approach that might be taken by many contract research organizations could result studies that don’t always best fit clients’ needs.

“We are also looking to develop a specialized clinical research arm, by partnering with other firms or acquiring their assets,” ​Griffin said. 

“There are a lot of CROs out there. But for claims substantiation, we have found that there can be a disconnect there. There can be more effective ways to conduct studies and do patient acquisition.  For a wrinkle reduction claim, say, you don’t need five PhDs and a toxicologist to do that kind of study,” ​he said.

Related topics: Markets

Related news

Follow us

Products

View more

Webinars